Evaluation of Fibrin Sealant 2 in Vascular Surgical Procedures
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00154141|
Recruitment Status : Completed
First Posted : September 12, 2005
Last Update Posted : July 13, 2006
|Condition or disease||Intervention/treatment||Phase|
|Peripheral Vascular Disease||Drug: Fibrin sealant (FS2)||Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||150 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||A Prospective, Randomized Controlled Study to Compare the Effects of a Fibrin Sealant (FS2) Versus Manual Compression on Haemostatic Efficacy During Vascular Surgical Procedures Utilising Polytetrafluorethylene Graft Material on an End-to-Side Femoral or Upper Extremity Vascular Access Arterial Anastomosis|
|Study Start Date :||June 2005|
|Study Completion Date :||March 2006|
- Attainment of hemostasis at following randomization.
- Attainment of hemostasis following randomization.
- Incidence of treatment failures
- Incidence of potential bleeding-related complications
- Adverse events
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00154141